6533b823fe1ef96bd127e175

RESEARCH PRODUCT

A quantum mechanics/molecular mechanics study of the protein-ligand interaction for inhibitors of HIV-1 integrase.

Estanislao SillaEstanislao SillaVicent MolinerIñaki TuñónRaquel CastilloSergio MartíCláudio Nahum AlvesJuan Andrés

subject

chemistry.chemical_classificationModels MolecularbiologyChemistryStereochemistryOrganic ChemistryProteinsGeneral ChemistryInteraction energyHIV IntegraseLigand (biochemistry)LigandsMolecular mechanicsCatalysisIntegraseMolecular dynamicsEnzymeViral replicationComputational chemistryQuantum mechanicsbiology.proteinQuantum TheoryHIV Integrase InhibitorsProtein ligand

description

Human immunodeficiency virus type-1 integrase (HIV-1 IN) is an essential enzyme for effective viral replication. Diketo acids such as L-731,988 and S-1360 are potent and selective inhibitors of HIV-1 IN. In this study, we used molecular dynamics simulations, within the hybrid quantum mechanics/molecular mechanics (QM/MM) approach, to determine the protein-ligand interaction energy between HIV-1 IN and L-731,988 and 10 of its derivatives and analogues. This hybrid methodology has the advantage that it includes quantum effects such as ligand polarisation upon binding, which can be very important when highly polarisable groups are embedded in anisotropic environments, as for example in metal-containing active sites. Furthermore, an energy decomposition analysis was performed to determine the contributions of individual residues to the enzyme-inhibitor interactions on averaged structures obtained from rather extensive conformational sampling. Analysis of the results reveals first that there is a correlation between protein-ligand interaction energy and experimental strand transfer into human chromosomes and secondly that the Asn-155, Lys-156 and Lys-159 residues and the Mg(2+) ion are crucial to anti-HIV IN activity. These results may explain the available experimental data.

10.1002/chem.200700040https://pubmed.ncbi.nlm.nih.gov/17570717